Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,551	1,525	1,581	1,393	1,196	1,060
Cash & Short-Term Investments	1,551	1,525	1,581	1,393	1,196	1,060
Cash Growth	2.06%	-3.56%	13.48%	16.54%	12.76%	2.61%
Accounts Receivable	606.38	644.94	610.53	575.98	510.95	512.64
Other Receivables	14.25	11.6	18.09	28.41	16.58	28.24
Receivables	620.63	656.54	628.62	604.39	527.53	540.88
Inventory	236.84	232.19	247.9	248.09	226.96	222.4
Prepaid Expenses	-	0.51	2.38	6.48	2.98	-
Other Current Assets	79.14	42.08	48.36	57.64	77.08	91.51
Total Current Assets	2,488	2,456	2,508	2,310	2,030	1,915
Property, Plant & Equipment	668.93	688.71	705.33	765.54	766.09	733.46
Long-Term Investments	654.05	736.84	779.96	804.31	886.53	872.49
Goodwill	702.91	702.91	702.91	702.91	702.91	722.63
Other Intangible Assets	95.98	100.45	101.42	111.73	133.96	147.95
Long-Term Accounts Receivable	-	28.47	37.45	52	65.9	68.95
Long-Term Deferred Tax Assets	92.44	92.95	81.8	56.02	46.94	47.83
Long-Term Deferred Charges	163.64	165.22	159.98	148.88	141.13	130.63
Other Long-Term Assets	382.83	277.08	334	333.2	259.72	240.52
Total Assets	5,249	5,249	5,411	5,285	5,033	4,880
Accounts Payable	132.37	47.32	68.76	56.85	32.12	43.21
Accrued Expenses	43.48	170.15	146.96	134.91	132.33	120.21
Current Portion of Long-Term Debt	42.31	-	6.31	6.31	6.31	9.34
Current Portion of Leases	-	43.75	23.34	21.19	16.69	-
Current Income Taxes Payable	30.39	6.71	17.93	30.38	24.97	20.99
Current Unearned Revenue	1,133	1,134	1,137	1,112	1,078	1,024
Other Current Liabilities	85.51	85.4	81.29	109.64	105.56	82.41
Total Current Liabilities	1,467	1,487	1,482	1,471	1,396	1,300
Long-Term Debt	-	-	9.46	15.77	22.08	37.53
Long-Term Leases	77.27	80	88.37	97.9	37.11	11.6
Long-Term Unearned Revenue	9.43	9.56	10.02	10.92	11.08	13.64
Long-Term Deferred Tax Liabilities	12.54	12.95	23.15	34.87	34.7	14.41
Total Liabilities	1,566	1,590	1,613	1,631	1,501	1,377
Common Stock	467.95	467.95	467.95	467.95	467.95	467.95
Additional Paid-In Capital	3,374	3,374	3,377	3,384	3,383	3,378
Retained Earnings	-165.89	-193.92	-294.27	-400.73	-513.71	-687.7
Treasury Stock	-200.03	-200.03	-	-	-	-
Comprehensive Income & Other	145.65	147.54	133.31	104.7	125.98	238.53
Total Common Equity	3,621	3,595	3,684	3,556	3,463	3,396
Minority Interest	61.5	63.98	114.55	97.85	69.31	106.03
Shareholders' Equity	3,683	3,659	3,799	3,654	3,533	3,502
Total Liabilities & Equity	5,249	5,249	5,411	5,285	5,033	4,880
Total Debt	119.57	123.75	127.48	141.18	82.2	58.48
Net Cash (Debt)	1,432	1,401	1,454	1,252	1,113	1,002
Net Cash Growth	2.41%	-3.61%	16.09%	12.46%	11.14%	11.58%
Net Cash Per Share	3.10	3.07	3.14	2.66	2.37	2.13
Filing Date Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Total Common Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Working Capital	1,021	968.93	1,027	838.53	634.56	615.09
Book Value Per Share	7.94	7.89	7.87	7.60	7.40	7.26
Tangible Book Value	2,822	2,792	2,880	2,741	2,627	2,526
Tangible Book Value Per Share	6.19	6.12	6.15	5.86	5.61	5.40
Land	-	3.54	3.49	3.43	3.14	3.21
Buildings	-	546.68	482.6	497.7	558.38	560.89
Machinery	-	700.82	690.88	653.02	623.86	583.77
Construction In Progress	-	10.54	18.98	23.23	20.5	8.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.